tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

AEVEX (AVEX) Q2 2026 Earnings Call: Revenue Doubles, Guidance Raised, BlackSea Deal Announced

AEVEX (AVEX) Q2 2026 earnings call: revenue rose 100% to $201.8 million, FY2026 guidance increased, and a $650 million BlackSea deal was announced.
iconAEVEX Ord Shs Class A (Proposed)
TradingKey
Fri, Aug 14

Aveanna Healthcare (AVAH) Q2 2026 Earnings Call: Guidance Raised on Organic Growth

Aveanna Healthcare’s Q2 2026 earnings call covered 13.7% revenue growth, higher 2026 guidance, California rate gains and stronger long-term growth targets.
iconAveanna Healthcare Holdings Inc
TradingKey
Fri, Aug 14

AOSL Fiscal Q4 2026 Earnings Call: AI Growth Drives Mix, September Guidance at $176M

AOSL fiscal Q4 2026 earnings call: revenue reached $170.4 million, AI and server demand strengthened, and September revenue guidance was $176 million.
iconAlpha and Omega Semiconductor Ltd
TradingKey
Fri, Aug 14

Arrive AI (ARAI) Q2 2026 Earnings Call: AP3 Plus Ramp and Commercial Pipeline

Arrive AI reports Q2 2026 revenue of $14,700, a $14.1 million net loss, $5.1 million in liquidity and AP3 Plus shipments targeted for September.
iconArrive AI Inc
TradingKey
Fri, Aug 14

Ampco-Pittsburgh (AP) Q2 2026 Earnings Call: Profit Returns, Backlog Hits $385.4M

Ampco-Pittsburgh’s Q2 2026 earnings call detailed a return to profit, $9.8 million in adjusted EBITDA and backlog growth to $385.4 million.
iconAmpco-Pittsburgh Corp
TradingKey
Fri, Aug 14

Andersen Group (ANDG) Q2 2026 Earnings Call: Organic Growth Reaches 20.6%

Andersen Group Q2 2026 revenue rose 23.7% to $217.7 million as organic growth reached 20.6%. The company reaffirmed its full-year guidance.
iconAndersen Group Ord Shs Class A
TradingKey
Fri, Aug 14

American Shared Hospital Services (AMS) Q2 2026 Earnings Call: Revenue Rises 19.2%

American Shared Hospital Services’ Q2 2026 earnings call covered 19.2% revenue growth, $4.4 million in operating cash flow, refinancing and receivable risks.
iconAmerican Shared Hospital Services
TradingKey
Fri, Aug 14

Amcor (AMCR) Fiscal Q4 2026 Earnings Call: EPS Rises 23%, Synergies Reach $285 Million

Amcor’s fiscal Q4 2026 earnings call covered 23% EPS growth, $285 million in annual synergies and $1.80-$1.90 transition-period EPS guidance.
iconAmcor PLC
TradingKey
Fri, Aug 14

Allot (ALLT) Q2 2026 Earnings Call: SECaaS Growth and Higher Revenue Guidance

Allot Q2 2026 revenue rose 15% to $27.7 million as SECaaS grew 47%. Management raised 2026 revenue guidance to $115 million–$118 million.
iconAllot Ltd
TradingKey
Fri, Aug 14

Alliance Laundry (ALH) Q2 2026 Earnings Call: EBITDA Outlook Raised

Alliance Laundry Q2 2026 revenue rose 7% and adjusted EBITDA increased 12%. ALH raised its EBITDA growth outlook and lowered its year-end leverage target.
iconAlliance Laundry Holdings Ord Shs
TradingKey
Fri, Aug 14

Allogene Therapeutics (ALLO) Q2 2026 Earnings Call: ALPHA3 Site Expansion and Pipeline Updates

Allogene Therapeutics’ Q2 2026 earnings call covers ALPHA3’s 100-site target, FDA designations, ALLO-316 results and ALLO-329’s Q4 update.
iconAllogene Therapeutics Inc
TradingKey
Fri, Aug 14

Applied Materials (AMAT) Fiscal Q3 2026 Earnings Call: Revenue Hits $9.1 Billion

Applied Materials fiscal Q3 2026 revenue rose 25% to $9.1 billion. AMAT guided Q4 revenue to $10.25 billion as AI, DRAM and packaging demand strengthened.
iconApplied Materials Inc
TradingKey
Fri, Aug 14

Altimmune (ALT) Q2 2026 Earnings Call: PERFORMA Starts, Cash Reaches $519M

Altimmune Q2 2026 earnings call: PERFORMA Phase III enrollment begins, RECLAIM AUD data support pivotal planning, and cash reaches $519 million.
iconAltimmune Inc
TradingKey
Fri, Aug 14

AIRO Q2 2026 Earnings Call: Revenue Jumps 76%, Drone Backlog Reaches $163M

AIRO Q2 2026 earnings call: revenue rose 76% to $43.2 million, gross margin reached 64%, drone backlog hit $163 million, and guidance was reiterated.
iconAIRO Group Holdings Inc
TradingKey
Fri, Aug 14

AIxCrypto Holdings (AIXC) Q2 2026 Earnings Call: RoboShare Push Amid Tight Liquidity

AIxCrypto Holdings (AIXC) Q2 2026 earnings call: net loss narrowed sequentially to $4.19 million as RoboShare became the priority amid tight liquidity.
iconAIxCrypto Holdings Ord Shs
TradingKey
Fri, Aug 14

AFCG Q2 2026 Earnings Call: NAV Rises, Pipeline Reaches $1.3 Billion

AFCG’s Q2 2026 earnings call covered $3.5 million in net investment income, $8.25 NAV per share, a 13.2% portfolio yield and a $1.3 billion pipeline.
iconAdvanced Flower Capital Inc
TradingKey
Fri, Aug 14

Applied Industrial Technologies (AIT) Fiscal Q4 2026 Earnings Call: Organic Sales Rise 9.7%

Applied Industrial Technologies’ fiscal Q4 2026 sales rose 10.4% as margins expanded. Review AIT’s segment results and fiscal 2027 guidance.
iconApplied Industrial Technologies Inc
TradingKey
Fri, Aug 14

AudioEye (AEYE) Q2 2026 Earnings Call: EBITDA Guidance Raised

AudioEye Q2 2026 revenue rose 9% to $10.7 million, ARR reached $42.3 million, and management raised full-year adjusted EBITDA guidance.
iconAudioEye Inc
TradingKey
Fri, Aug 14

Aebi Schmidt (AEBI) Q2 2026 Earnings Call: EBITDA Up 22%, Backlog Near $1.3B

Aebi Schmidt Q2 2026 earnings call: sales rose 9.4% to $496 million, adjusted EBITDA gained 22%, backlog reached $1.3 billion, and guidance was confirmed.
iconAebi Schmidt Holding AG
TradingKey
Fri, Aug 14

ADC Therapeutics (ADCT) Q2 2026 Earnings Call: LOTIS-5 FDA Concerns, $219.1M Cash

ADC Therapeutics Q2 2026 earnings call: ZYNLONTA revenue reached $18.6 million, while FDA concerns clouded the LOTIS-5 regulatory path.
iconADC Therapeutics SA
TradingKey
Fri, Aug 14
Featured Tools
marketing_marketsTitleMarketscalendar_economicCalendarEconomic Calendarsearch.intelligent.strategySmartPicksarticle_asider_weekly_reportWeekly Report
Popular Instruments
link
Name
Price
Chg%
US30
US30
US30
--
--
NAS100
NAS100
NAS100
--
--
SPX500
SPX500
US500
--
--
Top News
link
Meta Q3 Net Profit Surges 264% YoY, Raises Full-Year Capex Slightly; Shares Briefly Rise Over 4% After Hours
Tesla Q3 Operating Profit Plunges 56% YoY, Dragged Down by Higher Operating Expenses Including R&D
Meta Q3 2026 Earnings: Legal Charge Halves Operating Margin Despite 26% Revenue Growth
US Stocks Close: Nasdaq Gains Over 1%, Philadelphia Semiconductor Index Rises Nearly 2%; Tech Stocks Strengthen, SpaceX Gains Nearly 8% Post-Earnings
Meta Q3 Earnings Preview: Muse Commercialization Faces Test, Wall Street High Target Price Hits $1,000
Market Movers
link
Silver/AUD (XAGAUD) Is down 2.12% on Oct 22: What Is Driving the Move?
17 minutes ago
XAGAUD
--
Micro Silver (XAGUSD-M) Moved Sharply on Oct 22: Inventories, the Dollar, or Geopolitics?
47 minutes ago
XAGUSD-M
--
Silver (XAGUSD) Drops on Oct 22: What Lie behind the Move?
52 minutes ago
XAGUSD
--
Palladium (XPDUSD) Is down 2.53% on Oct 22: Is the Market Repricing It?
57 minutes ago
XPDUSD
--
Bitcoin (BTCUSD) Volatility Intensified on Oct 22: What You Should Know
an hour ago
BTCUSD
--
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy